Knight Therapeutics Inc

Insider Reports History

Entity
Company
Location
3400 Boulevard De Maisonneuve West, Suite 1055, Montreal, Quebec, Canada
Signature
KNIGHT THERAPEUTICS INC. By: /s/ Samira Sakhia, President and Chief Executive Officer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Knight Therapeutics Inc:

Stock Role Class Num Shares Value Price $ Report Date Ownership
60 DEGREES PHARMACEUTICALS, INC. Former 10% Owner Common Stock, $0.0001 par value per share ("Common Shares") 1.15M $5.48M $4.75 Jul 28, 2023 By Knight Therapeutics International S.A.
Synergy CHC Corp. 10%+ Owner Common Stock, par value $0.00001 per share 1.48M Oct 22, 2024 Held through Knight Therapeutics International SA, a subsidiary of Knight Therapeutics Inc.
60 DEGREES PHARMACEUTICALS, INC. Former 10% Owner Series A Non-Voting Convertible Preferred Stock 78.8K Jul 28, 2023 By Knight Therapeutics International S.A.

Insider Reports Filed by Knight Therapeutics Inc

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SNYR Synergy CHC Corp. Oct 22, 2024 0 $0 3 Oct 22, 2024 10%+ Owner
SXTP 60 DEGREES PHARMACEUTICALS, INC. Jul 28, 2023 2 $216K 4 Apr 3, 2024 Former 10% Owner
SXTP 60 DEGREES PHARMACEUTICALS, INC. Jul 11, 2023 0 $0 3 Dec 18, 2023 10%+ Owner